[Form 4] CLOROX CO /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Russell J. Weiner, a director of Clorox Co. (CLX), received additional deferred stock units (DSUs) under the company's Independent Directors' Deferred Compensation Plan. On 08/29/2025 he was credited with 156.7731 DSUs via dividend reinvestment and on 09/30/2025 he received 253.4469 DSUs in lieu of quarterly director fees. The reported DSUs will be settled 100% in Clorox common stock when the reporting person retires or otherwise terminates service as a director. After these transactions the reporting person beneficially owned 15,354.2406 DSUs (expressed as common stock equivalents) held directly.

Positive

• Director increased equity alignment with an additional 253.4469 DSUs received in lieu of fees
• Dividend reinvestment credited 156.7731 DSUs, showing use of equity-based compensation

Negative

• No negative items disclosed

Insights

Corporate Governance Analyst

Director received modest additional equity via DSUs; settlement is deferred until termination.

The reporting shows 156.7731 DSUs from dividend reinvestment and 253.4469 DSUs received in lieu of fees, both added to the director's direct holdings. These units are contractual deferred compensation that convert 1-for-1 into Clorox common stock upon the director's retirement or termination, so there is no immediate change to the companys outstanding shares.

This filing is routine compensation reporting under Section 16 and does not disclose sales or option exercises; it documents grant and reinvestment activity that increases the directors long-term equity stake to 15,354.2406 shares equivalent.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

WEINER RUSSELL J

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	08/29/2025		A(2)	V	156.7731		(3)	(3)	Common Stock	156.7731	$0.0000	15,100.7937	D
Deferred Stock Units	(1)	09/30/2025		A(4)		253.4469		(3)	(3)	Common Stock	253.4469	$0.0000	15,354.2406	D

Explanation of Responses:

1. 1-for-1

2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

	By Jinho Joo, Attorney-in-Fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for CLX report regarding Russell J. Weiner?

The Form 4 reports that director Russell J. Weiner received 156.7731 DSUs on 08/29/2025 and 253.4469 DSUs on 09/30/2025 under the Independent Directors' Deferred Compensation Plan.

How many DSUs does Russell J. Weiner beneficially own after the reported transactions?

Following the reported transactions, the reporting person beneficially owned 15,354.2406 DSU equivalents held directly.

How and when will the Deferred Stock Units be settled?

The DSUs will be settled 100% in Clorox common stock in connection with the reporting person's retirement or other termination of service as a director.

Why were additional DSUs granted on 09/30/2025?

The 253.4469 DSUs on 09/30/2025 were received in lieu of quarterly director's fees, per the filing.

Were any shares sold or exercised in this Form 4?

No; the filing records only acquisitions of DSUs via dividend reinvestment and fee deferral, with no dispositions reported.